Erik Manting
Chief Executive Officer at MENDUS AB
Net worth: 58 933 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alex Karlsson-Parra | M | 74 | 22 years | |
| Hans Preusting | M | 62 |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands.
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | 5 years |
| Thomas Fitzgerald | M | 73 | 6 years | |
| Jeroen Rovers | M | 54 |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | - |
| Zdravka Medarova | M | 50 | 8 years | |
| Philippe Calais | M | 65 | 6 years | |
| Christine Lind | F | 50 | 4 years | |
| Andrea van Elsas | M | 58 |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | 6 years |
| Magda Marquet | M | 65 | 3 years | |
| Susan Duggan | F | - | - | |
| Seth Gregg | M | - | - | |
| Alan Freidman | M | - | - | |
| Sven Arne Andréasson | M | 72 | 4 years | |
| Lotta Ferm | F | 58 | 3 years | |
| Léopold Bertea | M | 60 | 2 years | |
| Ted Ingemar Jakob Fjällman | M | 46 |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | 3 years |
| Dharminder Singh Chahal | M | 48 | 3 years | |
| Helén Tuvesson | M | 62 | 4 years | |
| Anna Koptina Gültekin | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Dudley | M | 74 | 8 years | |
| Dustan Bonnin | M | - | 2 years | |
| Leonne van der Sar | F | 55 |
Kempen & Co. NV
 Kempen & Co. NV Financial ConglomeratesFinance Kempen & Co. NV provides financial services to professional investors. The company's clients include institutional investors, companies, financial institutions, public & semi-public institutions, foundations and high-net-worth private clients. The company was founded in July 1903 by A. J. Kempen and M. D. de Lange and is headquartered in Amsterdam, The Netherlands. | - |
| Qiyong Liu | M | 60 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 11 | 47.83% |
| United States | 10 | 43.48% |
| Netherlands | 5 | 21.74% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erik Manting
- Personal Network
